FDA Grants Breakthrough Therapy Designation to Groundbreaking CAR-T Cell

FDA Grants Breakthrough Therapy Designation to Groundbreaking CAR-T Cell

A groundbreaking advancement in cell-based immunotherapy has emerged from Washington University School of Medicine in St. Louis, where researchers have developed a novel CAR-T cell therapy designated as a Breakthrough Therapy by the U.S. Food and Drug Administration (FDA). This innovative therapeutic approach, licensed to Wugen—a biotech startup rooted in the Cortex Innovation District of […]